Page last updated: 2024-10-30
lomustine and Congenital Thrombotic Thrombocytopenic Purpura
lomustine has been researched along with Congenital Thrombotic Thrombocytopenic Purpura in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Glas, M | 1 |
| Hennemann, B | 1 |
| Hirschmann, B | 1 |
| Marienhagen, J | 1 |
| Schmidt-Wolf, I | 1 |
| Herrlinger, U | 1 |
| Bogdahn, U | 1 |
| Hau, P | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| Phase I/II Study of Lutathera in Pediatric and Young Adult Patients With Recurrent and/or Progressive High-Grade Central Nervous System Tumors and Meningiomas That Express Somatostatin Type2A Receptors and Demonstrate Uptake on DOTATATE PET[NCT05278208] | Phase 1/Phase 2 | 65 participants (Anticipated) | Interventional | 2022-11-21 | Recruiting |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Other Studies
1 other study available for lomustine and Congenital Thrombotic Thrombocytopenic Purpura